DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Kreuz W, Escuriola Ettingshausen C, Vdovin V. , et al; ObsITI study group and the ObsITI committee.
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
Haemophilia 2016;
22 (01) 87-95
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.